zoledronic acid has been researched along with SAPHO Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Tsai, YS; Wang, CR; Whang-Peng, J | 1 |
| Castellanos-Moreira, R; Del Amo, M; Guañabens, N; Muxí, A; Peris, P; Rodriguez-García, SC | 1 |
| Kopterides, P; Koufos, C; Pikazis, D | 1 |
3 other study(ies) available for zoledronic acid and SAPHO Syndrome
| Article | Year |
|---|---|
Zoledronic acid monotherapy improves osteoarticular involvement in SAPHO syndrome.
Topics: Acquired Hyperostosis Syndrome; Bone Density Conservation Agents; Female; Humans; Joint Diseases; Middle Aged; Treatment Outcome; Zoledronic Acid | 2020 |
Imaging Follow-up of SAPHO Syndrome Treated With Zoledronic Acid.
Topics: Acquired Hyperostosis Syndrome; Diagnostic Imaging; Follow-Up Studies; Humans; Zoledronic Acid | 2020 |
Successful treatment of SAPHO syndrome with zoledronic acid.
Topics: Acquired Hyperostosis Syndrome; Adolescent; Diphosphonates; Humans; Imidazoles; Male; Treatment Outcome; Zoledronic Acid | 2004 |